Company Analysis

DiaMedica Therapeutics Inc. (DMAC)

Nasdaq: DMAC · Pharmaceutical Preparations · Minneapolis, MN · filing with the SEC since 2007
Grade5.0
◀ Past 5.0● Present 5.0▶ Future 5.0
5 est.

Who runs DiaMedica Therapeutics Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Pauls Dietrich John
President & CEO. First filing Dec 2018, latest Aug 12, 2026, 5 filings in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
20 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Pauls Dietrich JohnPresident & CEODec 2018Aug 12, 2026none
Kellen ScottCFO & SecretaryDec 2018Jun 3, 2026none
Krop JulieChief Medical OfficerNov 2025Jun 3, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Giuffre Randall MichaeldirectorDec 2018Jun 3, 2026none
Kuntz RicharddirectorMay 2023Jun 3, 2026none
Lewis TanyadirectorMar 2023Jun 3, 2026none
O'Connor Daniel J.directorFeb 2025Jun 3, 2026none
Parsons James T.directorDec 2018Jun 3, 2026none
Semba Charles PaulingdirectorJul 2021Jun 3, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Stahlberg Jan10% ownerJun 2023Dec 8, 2025none
Trill Ab10% ownerJun 2023Dec 8, 2025none
Jacinto Richard II10% ownerJun 2023Jul 25, 2025none
Tomenterprise Ab10% ownerJul 2022Jul 25, 2025none
Tomeqt Private Ab10% ownerDec 2022Jul 25, 2025none
Von Koch Thomas10% ownerJul 2022Jul 25, 2025none
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton DMAC · research, not advice